What is NDC 10122-180?

10122-180 is the product NDC for Lamzede (velmanase alfa-tycv), Velmanase alfa-tycv 10 mg/1 injection, powder, lyophilized, for solution, listed with the FDA by Chiesi USA, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.

Chiesi USA, Inc., NDC labeler code 10122. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lamzede?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lamzede NDC 10122-180 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)10122-180Labeler and product segments. Claims need a package NDC.

Product NDC at billing width10122-0180Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
10122-180-02	10122018002	1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (10122-180-02)Marketed from Mar 1, 2023
10122-180-05	10122018005	5 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (10122-180-05)Marketed from Mar 1, 2023
10122-180-10	10122018010	10 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (10122-180-10)Marketed from Mar 1, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lamzede
Generic name (nonproprietary): velmanase alfa-tycv
Active ingredients: Velmanase alfa-tycv — 10 mg/1
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Chiesi USA, Inc.NDC labeler code 10122
Product type: Prescription drug
Marketing category: BLA — Biologics License ApplicationApplication BLA 761278
Marketing start: Mar 1, 2023
Listing expires: Dec 31, 2026
Identifiers: Product ID 10122-180_27cf090b-196e-4330-8184-c72d9bb90660SPL ID 27cf090b-196e-4330-8184-c72d9bb90660SPL set ID 36d50a08-60bd-40eb-807c-778d69bf2d2eRxCUI 2630729, 2630734UNII M91TG242P2

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N410122018002 followed by a unit qualifier and the quantity

Package 10122-0180-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 21, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

1 INDICA TIONS AND USAGE LAMZEDE is indicated for the treatment of non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients. LAMZEDE is recombinant human lysosomal alpha-mannosidase indicated for the treatment of non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 10122-180

What is NDC 10122-180?: 10122-180 is the product NDC for Lamzede (velmanase alfa-tycv), Velmanase alfa-tycv 10 mg/1 injection, powder, lyophilized, for solution, listed with the FDA by Chiesi USA, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lamzede (Velmanase alfa-tycv).
What is the active ingredient?: Velmanase alfa-tycv.
Who is the labeler?: Chiesi USA, Inc., NDC labeler code 10122. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lamzede?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Lamzede (Velmanase alfa-tycv) NDC 10122-180